Director · Protagonist Therapeutics, Inc (PTGX)

Sarah A. O'Dowd — Protagonist Therapeutics Director Compensation (2025)

Fiscal year 2025 director compensation for Sarah A. O'Dowd at Protagonist Therapeutics, Inc. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

Protagonist Therapeutics Director Compensation Table · all 2 fiscal years held
In US dollars, as Protagonist Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$36,717$199,967$199,833$0$436,517
FY2024$51,549—$471,734$0$523,283

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protagonist Therapeutics, Inc DEF 14A filed April 28, 2026, accession 0001104659-26-050429, and prior-year filings. Open the filing on EDGAR.

The rest of the Protagonist Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Bryan GiraudoIndependent Director$431,816
Dinesh V. Patel, Ph.DDirector$0
Harold E. Selick, Ph.DChair of the Board$428,066
Lewis T. Williams, M.D., Ph.DIndependent Director$431,816
William D. WaddillIndependent Director$431,816

The full Protagonist Therapeutics compensation record

free company brief

This page is one director within Protagonist Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy